Advertisement

لوساردكس٥٠

المعلومات الرئيسية

  • اسم تجاري:
  • لوساردكس٥٠
  • الشكل الصيدلاني:
  • TABLETS
  • طريقة التعاطي:
  • PER OS
  • يسخدم من اجل:
  • البشر
  • نوع الدواء:
  • المخدرات الوباتشيك
  • المصنعة من قبل:
  • DEXCEL LTD
Advertisement

المستندات

الأقلمة

  • متاح في:
  • لوساردكس٥٠
    إسرائيل
  • اللغة:
  • العربية

معلومات العلاجية

  • المجموعة العلاجية:
  • LOSARTAN
  • الخصائص العلاجية:
  • Hypertension: Losardex is indicated for the treatment of hypertension. Heart failure: Losardex is indicated for the treatment of heart failure (NYHA II and III) usually in addition to diuretics and/or digitalis if use of an ACE inhibitor is not appropriate. Switching patients with heart failure who are stable on an ACE inhibitor to Losardex is not recommended. Renal protection in Type-2 diabetic patients with proteinuria: Losardex is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. Losardex is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventric

معلومات أخرى

الحالة

  • المصدر:
  • Ministry of Health - State of Israel
  • تخويل:
  • 138193149100
  • تاريخ الترخيص:
  • 01-03-2013
  • اخر تحديث:
  • 09-08-2016

معلومات المرضى النشرة


1-2-2018

Scientific guideline:  Dolutegravir film-coated tablets 10 mg, 25 mg and 50 mg product-specific bioequivalence guidance - First version, adopted

Scientific guideline: Dolutegravir film-coated tablets 10 mg, 25 mg and 50 mg product-specific bioequivalence guidance - First version, adopted

This guidance provides product-specific guidance on the demonstration of the dolutegravir.

Europe - EFSA - European Food Safety Authority EFSA Journal

15-2-2018

LINCOMYCIN S 50 (Lincomycin Spectinomycin) Powder [Aspen Veterinary Resources]

LINCOMYCIN S 50 (Lincomycin Spectinomycin) Powder [Aspen Veterinary Resources]

Updated Date: Feb 15, 2018 EST

US - DailyMed

14-2-2018

Cozaar vs. Lisinopril

Cozaar vs. Lisinopril

Cozaar (losartan) and lisinopril are used to treat hypertension. Lisinopril is also used to treat congestive heart failure and to improve survival after a heart attack. Cozaar and lisinopril belong to different drug classes. Cozaar is an angiotensin receptor blocker (ARB) and lisinopril is an angiotensin-converting enzyme inhibitor(ACE). Brand names for lisinopril include Zestril, Prinivil, and Qbrelis.

US - RxList

13-2-2018

AMOXICILLIN AND CLAVULANATE POTASSIUM Tablet, Film Coated [Northstar RxLLC]

AMOXICILLIN AND CLAVULANATE POTASSIUM Tablet, Film Coated [Northstar RxLLC]

Updated Date: Feb 13, 2018 EST

US - DailyMed

12-2-2018

HAWAIIAN NATURAL ZINC SUNSCREEN SPF 50 (Zinc Oxide) Lotion [Kokua Sun Care]

HAWAIIAN NATURAL ZINC SUNSCREEN SPF 50 (Zinc Oxide) Lotion [Kokua Sun Care]

Updated Date: Feb 12, 2018 EST

US - DailyMed

6-2-2018

POTASSIUM CHLORIDE Tablet, Film Coated, Extended Release [Sandoz Inc.]

POTASSIUM CHLORIDE Tablet, Film Coated, Extended Release [Sandoz Inc.]

Updated Date: Feb 6, 2018 EST

US - DailyMed

6-2-2018

POTASSIUM CHLORIDE Injection, Solution, Concentrate [Cardinal Health]

POTASSIUM CHLORIDE Injection, Solution, Concentrate [Cardinal Health]

Updated Date: Feb 6, 2018 EST

US - DailyMed

6-2-2018

KLOR-CON M (Potassium Chloride) Tablet, Extended Release [Sandoz Inc.]

KLOR-CON M (Potassium Chloride) Tablet, Extended Release [Sandoz Inc.]

Updated Date: Feb 6, 2018 EST

US - DailyMed

5-2-2018

UV PROTECT FACE SPF 50 (Zinc Oxide, Titanium Dioxide) Cream [NAOS]

UV PROTECT FACE SPF 50 (Zinc Oxide, Titanium Dioxide) Cream [NAOS]

Updated Date: Feb 5, 2018 EST

US - DailyMed

5-2-2018

NO SUN FACE SPF 50 (Zinc Oxide, Titanium Dioxide) Cream [NAOS]

NO SUN FACE SPF 50 (Zinc Oxide, Titanium Dioxide) Cream [NAOS]

Updated Date: Feb 5, 2018 EST

US - DailyMed

5-2-2018

50% RUBBING (Isopropyl Alcohol) Liquid [Geiss, Destin Dunn, Inc]

50% RUBBING (Isopropyl Alcohol) Liquid [Geiss, Destin Dunn, Inc]

Updated Date: Feb 5, 2018 EST

US - DailyMed

2-2-2018

FRESH-S (Potassium Carbonate) Liquid [NARO, INC.]

FRESH-S (Potassium Carbonate) Liquid [NARO, INC.]

Updated Date: Feb 2, 2018 EST

US - DailyMed

1-2-2018

Cozaar vs. Atenolol

Cozaar vs. Atenolol

Cozaar (losartan) and atenolol are used to treat hypertension. Atenolol is also used to treat chest pain (angina), for management of acute heart attack (myocardial infarction), and occasionally for thyroid storm management. Cozaar and atenolol belong to different drug classes. Cozaar is an angiotensin receptor blocker (ARB) and atenolol is a beta-blocker.

US - RxList

1-2-2018

Cozaar vs. Avapro

Cozaar vs. Avapro

Cozaar (losartan) and Avapro (irbesartan) are angiotensin receptor blockers (ARBs) used to treat hypertension. Avapro is also sometimes given together with other blood pressure medications. Avapro is also used to treat kidney problems caused by type 2 (non-insulin-dependent) diabetes.

US - RxList

1-2-2018

Cozaar vs. Diovan

Cozaar vs. Diovan

Cozaar (losartan) and Diovan (valsartan) are angiotensin receptor blockers (ARBs) that are prescribed for treating hypertension. Diovan is also used after a heart attack and to treat heart failure.

US - RxList

1-2-2018

Cozaar vs. Hyzaar

Cozaar vs. Hyzaar

Cozaar (losartan) and Hyzaar (losartan potassium-hydrochlorothiazide) are prescribed for the treatment of hypertension. Hyzaar is also used to lower the risk of stroke in certain people with heart disease. Cozaar and Hyzaar both contain an angiotensin receptor blocker (ARB), and Hyzaar is a combination medication that also contains a thiazide diuretic (water pill).

US - RxList

31-1-2018

Scientific guideline:  Draft cholic acid capsules 50 mg and 250 mg product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft cholic acid capsules 50 mg and 250 mg product-specific bioequivalence guidance, draft: consultation open

Cholic acid capsules 50 mg and 250 mg product-specific bioequivalence guidance

Europe - EMA - European Medicines Agency

23-1-2018

POTASSIUM CHLORIDE Tablet, Film Coated, Extended Release [Major Pharmaceuticals]

POTASSIUM CHLORIDE Tablet, Film Coated, Extended Release [Major Pharmaceuticals]

Updated Date: Jan 23, 2018 EST

US - DailyMed

23-1-2018

POTASSIUM CHLORIDE Tablet, Extended Release [St Marys Medical Park Pharmacy .]

POTASSIUM CHLORIDE Tablet, Extended Release [St Marys Medical Park Pharmacy .]

Updated Date: Jan 23, 2018 EST

US - DailyMed

22-1-2018

XALKORI (Pfizer Limited)

XALKORI (Pfizer Limited)

XALKORI (Active substance: crizotinib) - Centralised - 2-Monthly update - Commission Decision (2018)415 of Mon, 22 Jan 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2489/II/50

Europe -DG Health and Food Safety

22-1-2018

Potassium Iodide

Potassium Iodide

Potassium iodide is a thyroid blocker indicated to help prevent radioactive iodine from getting into the thyroid gland during a nuclear radiation emergency.

US - RxList

Advertisement